Connect Biopharma Holdings Limited Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BML CAPITAL MANAGEMENT, LLC | 11/05/2024 | 2.09 M | $3.01 M | 2.45% | 3.80% |
| UBS OCONNOR LLC | 11/14/2024 | 510,701 | $725,195 | 0.00% | 0.93% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 175,500 | $252,702 | -17.33% | 0.32% |
| CALLAN CAPITAL, LLC | 11/12/2024 | 41,823 | $60,221 | 100.00% | 0.08% |
| KEUDELL/MORRISON WEALTH MANAGEMENT | 10/31/2024 | 33,450 | $48,165 | 3.88% | 0.06% |
| ROYAL BANK OF CANADA | 11/14/2024 | 30,600 | $44,000 | 140.94% | 0.06% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 27,961 | $39,704 | 0.00% | 0.05% |
| COMMONWEALTH EQUITY SERVICES, LLC | 10/18/2024 | 20,000 | $29,000 | 0.00% | 0.04% |
| RHUMBLINE ADVISERS | 11/12/2024 | 9,500 | $13,489 | 0.00% | 0.02% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 1,838 | $2,647 | 100.00% | 0.00% |
| JPMORGAN CHASE & CO | 12/26/2024 | 121 | $172 | 0.00% | 0.00% |
| MORGAN STANLEY | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
Connect Biopharma Holdings Limitedinstitutional Ownership - FAQ's
During the previous two years, 14 institutional investors and hedge funds held shares of Connect Biopharma Holdings Limited. The most heavily invested institutionals were:
BML Capital Management, LLC: 2.09 M
UBS OCONNOR LLC: 510,701
RENAISSANCE TECHNOLOGIES LLC: 175,500
Callan Capital, LLC: 41,823
Keudell/Morrison Wealth Management: 33,450
ROYAL BANK OF CANADA: 30,600
5.34% of Connect Biopharma Holdings Limited stock is owned by institutional investors.
Institutional investors have bought a total of 3.05 M shares in the last 24 months. This purchase volume represents approximately $2.99 M in transactions.